Begin.
Nine prompts built the substrate. This one converted commitment into beginning. The output is not a description of what beginning would look like. It is the first version of what was built.
UK Biobank Cross-Organ Imaging Phenotype Analysis
Aging is a systemic process with measurable cross-organ structural correlates. Brain white matter integrity, cardiac ejection fraction, and abdominal organ volumes co-vary in the same individuals in ways that predict disease outcomes better than any single organ measure alone.
Why chosen: Highest discovery probability in the portfolio (20–35%), clearest path to a field-level contribution, data exists and access pathway is established, analysis is tractable with current methods.
What Was Built
A complete data schema with UK Biobank field numbers, a working analysis pipeline, and a validated synthetic dataset — the prerequisites that must exist before any real data can be processed.
With this artifact, the program can: (1) submit a UK Biobank access application, (2) validate the analysis pipeline before real data arrives, (3) demonstrate the approach to potential collaborators, and (4) pre-register the analysis before seeing the real results.
Baseline Analysis (Synthetic Data)
These results are from synthetic data. They are not scientifically meaningful. They confirm the pipeline executes correctly and produces interpretable output.
Close to 33.3% expected for independent variables. On real data, if PC1 explains substantially more than 33%, it is evidence for a shared systemic aging component.
Cross-organ phenotype outperformed best single-organ predictor by 0.0095 AUC. In synthetic data, this reflects noise reduction from averaging, not real biology.
Single-organ (brain) outperformed cross-organ for dementia. Expected: dementia is primarily a brain disease. Cross-organ phenotype should not outperform for organ-specific outcomes.
All 6 analysis steps completed without errors on 2000-participant synthetic dataset. Pipeline is ready for real data.
What Building Revealed
Real work always produces this — the discovery of specific complications that planning did not anticipate.
The 33% Threshold as Null Hypothesis
The PCA result on synthetic data (PC1 = 34.4%, close to 33.3% expected for independent variables) provides a useful null hypothesis baseline that was not explicit in the program design.
Implication:On real data, if PC1 explains substantially more than 33%, it is evidence for a shared systemic aging component. This threshold should be pre-registered before analyzing real data.
Noise Reduction Baseline for Cross-Organ Phenotypes
Cross-organ phenotypes outperformed single-organ phenotypes for 3 of 6 outcomes in synthetic data with independent organ age gaps. This baseline improvement from noise reduction alone needs to be accounted for.
Implication:The analysis needs to test whether cross-organ phenotypes outperform single-organ phenotypes beyond what would be expected from noise reduction alone. This requires a permutation test or a comparison against a null model.
Liver Iron-Corrected T1 as Underspecified Variable
The UK Biobank abdominal MRI data includes liver iron-corrected T1 (a fibrosis marker) that was not in the original program design.
Implication:This variable should be included in the abdominal aging model. Liver fibrosis is a potentially important component of abdominal aging that is distinct from liver fat.
Organ-Specific Outcomes Require Separate Analysis
For organ-specific outcomes (dementia → brain, CKD → kidney), single-organ phenotypes outperformed cross-organ phenotypes in the synthetic data.
Implication:The analysis should explicitly test the hypothesis that cross-organ phenotypes outperform single-organ phenotypes for systemic outcomes (mortality, multi-morbidity) but not for organ-specific outcomes. This distinction is scientifically important.
What Someone Returning Tomorrow Would Do
Verify UK Biobank field numbers in docs/schema.md against the current UK Biobank data showcase (biobank.ndph.ox.ac.uk/showcase/). The most important fields to verify are the cardiac MRI fields (22420–22426) and the abdominal MRI fields (22402–22409).
Who: Can be done by anyone with internet access. No domain expertise required.
Submit UK Biobank access application. Register at ukbiobank.ac.uk/enable-your-research/apply-for-access. Required: institutional affiliation, ethics approval, data access agreement. Typical processing time: 3–6 months.
Who: Requires institutional affiliation and ethics approval. Must be a researcher at an accredited institution.
Train organ-specific age prediction models. Brain age: train on T1-weighted MRI features. Cardiac age: train on cardiac MRI features. Abdominal age: train on abdominal MRI features. Each model requires ~80% of the sample for training, 20% for validation.
Who: Requires a researcher with machine learning expertise and access to GPU compute.
Run the full pipeline on real data. Add site correction (ComBat or similar). Replace synthetic organ age gaps with model-predicted age gaps. Run the full analysis pipeline.
Who: Can be done by anyone who can run Python scripts with access to the UK Biobank data.
What This Prompt Could Not Do
The UK Biobank data already exists. No new data collection is required.
UK Biobank access requires institutional affiliation. A solo operator without institutional affiliation cannot access the data directly. A collaborator at an accredited institution is required.
The organ age prediction models require weeks of training on real data. They could not be produced in this session.
The schema and pipeline are both the achievable and the right first artifact. The organ age prediction models are the next most important artifact, but they require real data that is not yet available.
The artifact is real. It runs. It produces output. Someone could pick it up tomorrow and do the next piece. The nine prompts before this one produced not a document but a beginning.
MANUS AI — THE BEGINNING — SESSION 01 — MAY 2026
The nine prompts before this one produced not a document but a beginning.